Mike Masters

Chief Executive Officer at

Masters Capital Management LLC

Health Technology

Finance

Consumer Services

Profile

Mr. Michael W.
Masters is a Founder, Portfolio Manager & Chief Investment Officer at Masters Capital Management LLC.
He is on the Board of Directors at BioCircuit Technologies, Inc. and Celtaxsys, Inc. He founded Masters Capital Management in 1994 with a vision for an investment company that would align with his professional and personal values.
He is a graduate of the University of Tennessee.

Mike Masters active positions

Companies	Position	Start
Masters Capital Management LLC Masters Capital Management LLC Investment ManagersFinance Masters Capital Management aims to provide long-term outsized absolute returns on invested capital. The firm manages a single investment strategy pari passu across all fund structures. The strategy generally invests in US equities and listed equity options.	Chief Executive Officer	1993-12-31
BioCircuit Technologies, Inc. BioCircuit Technologies, Inc. Medical SpecialtiesHealth Technology Develops non-invasive electrophysiology devices	Director/Board Member	-

All active positions of Mike Masters

Former positions of Mike Masters

Companies	Position	End
Celtaxsys, Inc. Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases	Director/Board Member	-

See the detail of Mike Masters's experience

Training of Mike Masters

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mike Masters's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Masters Capital Management LLC Masters Capital Management LLC Investment ManagersFinance Masters Capital Management aims to provide long-term outsized absolute returns on invested capital. The firm manages a single investment strategy pari passu across all fund structures. The strategy generally invests in US equities and listed equity options.	Finance
Celtaxsys, Inc. Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases	Health Technology
University of Tennessee University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BioCircuit Technologies, Inc. BioCircuit Technologies, Inc. Medical SpecialtiesHealth Technology Develops non-invasive electrophysiology devices	Health Technology